In the News

Recent Coverage of HMS in the News
August 9, 2012

Six months after the US Food and Drug Administration required cholesterol-lowering statin drugs to carry warnings about diabetes risks, Brigham and Women’s Hospital researchers conclude in a new analysis of a landmark study that the increased likelihood of diabetes is outweighed by the drugs’ protective effects against heart attacks, strokes and heart disease deaths. Paul Ridker, the Eugene Braunwald Professor of Medicine at Brigham and Women’s Hospital, is the leader of the study. Allison Goldfine, HMS associate professor of medicine at Joslin Diabetes Center, is also quoted.

August 9, 2012

Desperate to stop Alzheimer's in its tracks, some caregivers are clamoring for a cancer drug shown to reverse the disease in mice. But experts argue prescribing the drug, while legal, is unethical. Clifford Saper, chair of the Department of Neurology at Beth Israel Deaconess Medical Center, is quoted.

August 8, 2012

T. Berry Brazelton, HMS clinical professor of pediatrics, emeritus, at Boston Children’s Hospital, authored this piece about advocating for children’s health.

August 8, 2012

The University of Cambridge will receive 8 million pounds ($12.5 million) to create a new stem- cell research center, joining those established at the University of Oxford and Harvard University.

August 8, 2012

Research by Gottfried Schlaug, HMS associate professor of neurology at Beth Israel Deaconess Medical Center, is featured at a three-day symposium on “Music, the Brain, Medicine and Wellness” in Santa Fe, New Mexico.

August 7, 2012

College of the Holy Cross student A. Joseph Dalton is hoping to gain insight into cardiac disorders by spending the summer in up-close and personal encounters with zebra fish. Dalton has been working under the supervision of Barry Paw, HMS associate professor of medicine at Brigham and Women’s Hospital.

August 7, 2012

American kids' and teens' cholesterol levels are, on a whole, improving, according to a new study. Sarah D. de Ferranti, HMS assistant professor of pediatrics at Boston Children’s Hospital, wrote an accompanying editorial.

August 7, 2012

Scientists have identified a role for inflammatory monocytes in the progression of amyotrophic lateral sclerosis (AML), indicating that these immune cells may represent a therapeutic target. Howard L. Weiner, the Robert L. Kroc Professor of Neurology at Brigham and Women’s Hospital, is the senior author of the study.

Pages

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.